![Robert Michiels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Michiels
Directeur/Membre du Conseil chez
Embolization Prevention Technologies
Profil
Robert Michiels is currently the Director at Embolization Prevention Technologies.
He is also an Independent Director at FEops NV, Director at Atrius Ltd., Director at Aegis Surgical Ltd., Founding Partner at Consilium Associates LLC, and Senior Venture Partner at 415 Capital Management GmbH.
In his former positions, Mr. Michiels served as the Chief Executive Officer & Director at Edwards Lifesciences CardiaQ LLC from 2011 to 2015.
He was also the Chief Executive Officer & Director at VenPro Corp., President, Chief Operating Officer & Director at Medtronic CoreValve LLC, President, Chief Operating Officer & Director at Interventional Technologies, Inc. from 1991 to 1998, Independent Director at EDAP TMS SA, and Chief Operating Officer at CoreValve SA from 2004 to 2009.
Mr. Michiels holds an MBA from Indiana University and an undergraduate degree from the University of Antwerp.
Postes actifs de Robert Michiels
| Sociétés | Poste | Début |
|---|---|---|
Embolization Prevention Technologies | Directeur/Membre du Conseil | - |
Consilium Associates LLC | Corporate Officer/Principal | 01/01/2000 |
Aegis Surgical Ltd.
 Aegis Surgical Ltd. Medical SpecialtiesHealth Technology Develops healthcare equipment for the treatment of symptomatic aortic stenosis | Directeur/Membre du Conseil | - |
FEops NV
 FEops NV Information Technology ServicesTechnology Services Develops AI-driven simulation technology and related platform for clinical heart interventions | Independent Dir/Board Member | 12/01/2023 |
415 Capital Management GmbH
 415 Capital Management GmbH Investment ManagersFinance 415 Capital is an active manager which provides equity financing for seed-, early-stage and growth capital requirements. It targets innovative MedTech companies located in Europe, the United States, and Israel. Typical transaction size ranges from EUR 1 million to EUR 5 million, and total investment size per company ranges from EUR 5 million to EUR 10 million. The firm seeks to acquire minority stakes in target companies. | Private Equity Investor | - |
Anciens postes connus de Robert Michiels
| Sociétés | Poste | Fin |
|---|---|---|
Edwards Lifesciences CardiaQ LLC
 Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement | Directeur Général | 01/01/2015 |
CoreValve SA
 CoreValve SA Medical SpecialtiesHealth Technology Develops implants and instruments for heart surgery | Directeur des opérations | 01/01/2009 |
Interventional Technologies, Inc.
 Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures microsurgical devices | President | 01/01/1998 |
Atrius Ltd.
 Atrius Ltd. Medical/Nursing ServicesHealth Services Operates health care center | Directeur/Membre du Conseil | - |
| ░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Robert Michiels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
9
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
EDAP TMS SA
 EDAP TMS SA Medical SpecialtiesHealth Technology Develops, produces and markets minimally invasive medical devices for urological diseases | Health Technology |
Medtronic CoreValve LLC
 Medtronic CoreValve LLC Medical SpecialtiesHealth Technology Develops products that provide alternetive to heart valve replacement surgery | Health Technology |
Edwards Lifesciences CardiaQ LLC
Edwards Lifesciences CardiaQ LLC Medical SpecialtiesHealth Technology Operates as a medical device company which develops technologies for percutaneous mitral heart valve replacement | Health Technology |
Interventional Technologies, Inc.
Interventional Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures microsurgical devices | Health Technology |
VenPro Corp.
 VenPro Corp. Medical SpecialtiesHealth Technology Develops medical products | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoreValve SA
CoreValve SA Medical SpecialtiesHealth Technology Develops implants and instruments for heart surgery | Health Technology |
University of Antwerp
 University of Antwerp Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Embolization Prevention Technologies | |
Consilium Associates LLC | |
FEops NV
FEops NV Information Technology ServicesTechnology Services Develops AI-driven simulation technology and related platform for clinical heart interventions | Technology Services |
Atrius Ltd.
Atrius Ltd. Medical/Nursing ServicesHealth Services Operates health care center | Health Services |
Aegis Surgical Ltd.
Aegis Surgical Ltd. Medical SpecialtiesHealth Technology Develops healthcare equipment for the treatment of symptomatic aortic stenosis | Health Technology |
415 Capital Management GmbH
415 Capital Management GmbH Investment ManagersFinance 415 Capital is an active manager which provides equity financing for seed-, early-stage and growth capital requirements. It targets innovative MedTech companies located in Europe, the United States, and Israel. Typical transaction size ranges from EUR 1 million to EUR 5 million, and total investment size per company ranges from EUR 5 million to EUR 10 million. The firm seeks to acquire minority stakes in target companies. | Finance |
